Therapeutic potential of policosanol in the concurrent management of dyslipidemia and non-alcoholic fatty liver disease

Therapeutic potential of policosanol in the concurrent management of dyslipidemia and non-alcoholic fatty liver disease

Abstract Background High-fat diet (HFD) possesses a major cause of cardiovascular disease, and hepatosteatosis. Unfortunately, long-term use of statins has a theoretical possibility of worsening of hepatic histology in the patients with non-alcoholic fatty liver disease (NAFLD). The objective of the...

Full description

Bibliographic Details
Main Authors: Mandeep K. Arora, Sudhanshu Pandey, Ritu Tomar, Jagannath Sahoo, Dinesh Kumar, Ashok Jangra
Format: Article
Language:English
Published: SpringerOpen 2022-01-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Hepatotoxicity
Oxidative stress
Policosanol
Silymarin
Atorvastatin
Online Access:https://doi.org/10.1186/s43094-022-00399-4

Internet

https://doi.org/10.1186/s43094-022-00399-4

Similar Items